Three numbers in the abstract
Where each one falls
Where it lands on the map
the abstract, start to end
… prevented weight gain (mean weight gain, -3.07 kg [range, -3.85 to -2.28 kg]; P < .001), improved glycemic control (mean reduction in HbA(1c) level, 0.4% percentage point [95% CI, 0.55-0.25]; P < .001) (where CI indicates confidence interval), despite the aim of similar glycemic control in both groups, and reduced insulin requirements (mean reduction, 19.63 IU/d [95% CI, 24.91-14.36 …
← favours treatmentfavours comparator →
could be chanceWeight gainmetformin vs placebo, in null
−3.07−3.85 to −2.28
HbA(1c)metformin vs placebo, in null
−0.40−0.55 to −0.25
Insulin requirementsmetformin vs placebo, in null
−19.6−24.9 to −14.4
MetforminGlycemic controlBody weight & composition
1 / 3